Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.

Shirazi, Farah; Wang, Jennifer; Wong, Robert J

Shirazi, Farah; Wang, Jennifer; Wong, Robert J.

Afiliación

Shirazi F; Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA.
Wang J; Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA.
Wong RJ; Division of Gastroenterology and Hepatology, Alameda Health System - Highland Hospital, Oakland, CA, USA.

J Clin Exp Hepatol ; 10(1): 30-36, 2020.

Article en En | MEDLINE | ID: mdl-32025164

Palabras clave

ALD, alcoholic liver disease; DAA, direct acting antivirals; HCC; HCC, hepatocellular carcinoma; HCV; HCV, hepatitis C virus; LT, liver transplantation; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; WL, waitlist; baby boomer; direct-acting antiviral therapy; liver transplantation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Clin Exp Hepatol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google